scholarly journals A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma

2015 ◽  
Vol 20 (6) ◽  
pp. 617-618 ◽  
Author(s):  
Ryan J. Sullivan ◽  
Nageatte Ibrahim ◽  
Donald P. Lawrence ◽  
Julie Aldridge ◽  
Anita Giobbie‐Hurder ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Phase I ◽  
Phase I Trial ◽  
Advanced Malignant Melanoma

Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma

1992 ◽  
Vol 3 (1) ◽  
pp. 19-24 ◽  
Author(s):  
Mansoor N. Saleh ◽  
M.B. Khazaeli ◽  
Richard H. Wheeler ◽  
Laquetta Allen ◽  
Arabella B. Tilden ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Malignant Melanoma ◽  
Phase I ◽  
Phase I Trial

Phase I & Ib Trials of Murine Tyrosinase ± Human GM-CSF DNA Vaccination in Dogs with Advanced Malignant Melanoma

2005 ◽  
Vol 3 (1) ◽  
pp. 35-36
Author(s):  
P. J. Bergman ◽  
M. A. Camps-Palau ◽  
J. A. McKnight ◽  
N. F. Leibman ◽  
C. A. Novosad ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Phase I ◽  
Dna Vaccination ◽  
Gm Csf ◽  
Advanced Malignant Melanoma

Phase I Trial of Sorafenib in Combination with IFN α-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma

2007 ◽  
Vol 13 (6) ◽  
pp. 1801-1809 ◽  
Author(s):  
Bernard Escudier ◽  
Nathalie Lassau ◽  
Eric Angevin ◽  
Jean Charles Soria ◽  
Linda Chami ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Malignant Melanoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Trial

scholarly journals Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations

2005 ◽  
Vol 92 (6) ◽  
pp. 1006-1012 ◽  
Author(s):  
A Azzabi ◽  
A N Hughes ◽  
P M Calvert ◽  
E R Plummer ◽  
R Todd ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Phase I ◽  
Phase I Study ◽  
Advanced Malignant Melanoma
Sign in / Sign up

Export Citation Format

Share Document